| [1］ 中华医学会新生儿学组.中国城市早产儿流行病学初步调查报告［J］.中国当代儿科杂志，2005，7 (1):25-28. [2］ Petrini JR，Dias T，McCormick MC，et al.Increased risk of adverse neurological development for late preterm infants［J］.J Pediatr，2009，154(2):169-173. [3］ Magee L，Sawchuck D，Synnes A，et al.SOGC Clinical Practice Guideline.Magnesium sulphate for fetal neuroprotection［J］.J Obstet Gynaecol Can，2011，33(5):516-529. [4］ American college of obstetricians and gynecologists: committee on practice bulletins-obstetrics.ACOG practice bulletin no 127: Management of preterm labor［J］.Obstet Gynecol，2012，119(6):1308-1317. [5］ Moster D，Lie RT，Markestad T.Long-term medical and social consequences of preterm birth［J］.N Engl J Med, 2008，359(3):262-273. [6］ Vincer MJ，Allen AC，Joseph KS，et al.Increasing prevalence of cerebral palsy among very preterm infants: a population-based study［J］. Pediatr，2006，118(6):1621-1626. [7］ Woodward LJ，Anderson PJ，Austin NC，et al.Neonatal MRI to predict neurodevelopmental outcomes in preterm infants［J］.N Engl J Med，2006，355:685-694. [8］ McIntosh TK，Vink R，Yamakami I，et al.Magnesium protects against neurological deficit after brain injury［J］.Brain Res，1989，482(2):252-260. [9］ Hallak M，Cotton DB.Transfer of maternally administered magnesium sulfate into the fetal compartment of the rat［J］.Am J Obstet Gynecol，1993，169(2):427-431. [10］ Hallak M，Berry SM，Madincea F，et al.Fetal serum and amniotic fluid magnesium concentrations with maternal treatment［J］.Obstet Gynecol，1993，81(2):185-188. [11］ Shogi T，Miyamoto A，Ishiguro S，et al.Enhanced release of IL-1 beta and TNF-alpha following endotoxin challenge from rat alveolar macrophages cultured in low-Mg2+ medium［J］.Magnesium Res，2003，16(2):111-119. [12］ Nowak L，Bregestovski P，Ascher P，et al.Magnesium gates glutamate-activated channels in mouse central neurons［J］.Nature，1984，307(5950):462-465. [13］ Goi-de-Cerio F，Alvarez A，Lara-Celador I，et al.Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs［J］.Res，2012，90(10):1932-1940. [14］ Kuban KCK，Leviton A，Pagano M，et al.Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies［J］.J Child Neurol，1992，7(1):70-76. [15］ Nelson KB，Grether JK.Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants?［J］.Pediatr，1995，95(2):263-269. [16］ Costantine MM，How HY，Coppage K，et al.Does peripartum infection increase the incidence of cerebral palsy in extremely low birth weight infants?［J］.Am J Obstet Gynecol，2007，196(5):6-8. [17］ Doyle LW，Crowther CA，Middleton P，et al.Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.Cochrane Database of Systematic Reviews，2009，1.［DOI: 10.1002/14651858.CD004661.pub3］. [18］ Mittendorf R，Dambrosia J，Pryde PG，et al.Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants［J］.Am J Obstet Gynecol， 2002，186(6):1111-1118. [19］ Crowther CA，Hiller JE，Doyle LW，et al.Effect of magnesium sulfate given for neuroprotection before preterm birth［J］.JAMA，2003，290(20):2669-2676. [20］ Magpie Trial Follow-Up Study Collaborative Group.The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia.Outcome for children at 18 months［J］.BJOG，2007，114(3):289-299. [21］ Marret S，Marpeau L，Zupan-Simunek V，et al.Magnesium sulfate given before very preterm birth to protect infant brain: the randomized controlled PREMAG trial［J］.BJOG，2007，114(3):310-318. [22］ Rouse DJ，Hirtz DG，Thom E，et al.A randomized controlled trial of magnesium sulfate for the prevention of cerebral palsy［J］.N Engl Med，2008，359(9):895-905. [23］ The Antenatal Magnesium Sulphate for Neuroprotection Guideline Development Panel.Antenatal Magnesium Sulphate Prior to Preterm Birth for Neuroprotection of the Fetus，Infant and Child: National Clinical Practice Guidelines.Adelaide: The University of Adelaide，2010. [24］ Reeves SA，Gibbs RS，Clark SL.Magnesium for fetal neuroprotection［J］.Am J Obstet Gynecol，2011，204(202):1-4. [25］ Food and Drug Administration.FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies.FDA Drug Safety Communication，Silver Spring (MD): FDA; 2013. [26］ American college of obstetricians and gynecologists committee on obstetric practice society for maternal-fetal medicine.Committee opinion No.573: Magnesium sulfate use in obstetrics［J］.Obstet Gynecol, 2013，122(3):727-728. |
